MR Imaging-Guided Interventions in the Genitourinary Tract: An Evolving Concept

Magnetic Resonance Imaging Clinics of North America

Volumn 18, Issue 1, 2010, Pages 11-28

  Fennessy, Fiona M ^a   Tuncali, Kemal ^a   Morrison, Paul R ^a   Tempany, Clare M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brachytherapy; Genitourinary tract; Magnetic resonance guided focused ultrasound surgery (MRgFUS); Prostate cancer; Radiofrequency ablation; Uterine fibroids

Indexed keywords

BRACHYTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CRYOABLATION; CRYOTHERAPY; DIAGNOSTIC ACCURACY; FOCUSED ULTRASOUND SURGERY; HUMAN; HYPERTHERMIC THERAPY; HYSTERECTOMY; IMAGE ANALYSIS; IONIZING RADIATION; KIDNEY CARCINOMA; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SELECTION; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; TREATMENT PLANNING; TUMOR LOCALIZATION; UROGENITAL TRACT DISEASE; UTERUS MYOMA;

EID: 70649091214     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2009.09.002     Document Type: Review

References (116)

1. Stewart A.J., and Viswanathan A.N. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. Cancer 107 5 (2006) 908-915
2. Stewart E.A. Uterine fibroids. Lancet 357 (2001) 293-298
3. Ravina J., Herbreteau D., Ciraru-Vigneron N., et al. Arterial embolisation to treat uterine myomata. Lancet 346 (1995) 671-672
4. Lynn J.G., Zwemer R.L., Chick A.J., et al. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 26 (1942) 179-193
5. Fry W.J., Barnard J.W., and Fry F.J. Ultrasonically produced localized selective lesions in the central nervous system. Am J Phys Med 34 (1955) 413-423
6. Lele P.P. A simple method for production of trackless focal lesions with focused ultrasound: physical factors. J Physiol 160 (1962) 494-512
7. Heimburger R.F. Ultrasound augmentation of central nervous system tumor therapy. Indiana Med 78 (1995) 469-476
8. Gelet A., Chapelon J.Y., Bouvier R., et al. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 161 (1999) 156-162
9. Paterson R.F., Barret E., Siqueira Jr. T.M., et al. Laparoscopic partial kidney ablation with high intensity focused ultrasound. J Urol 169 1 (2003) 347-351
10. Yang R., Sanghvi N.T., Rescorla F.J., et al. Extracorporeal liver ablation using sonography-guided high-intensity focused ultrasound. Invest Radiol 27 10 (1992) 796-803
11. Watkin N.A., Morris S.B., Rivens I.H., et al. A feasibility study for the non-invasive treatment of superficial bladder tumours with focused ultrasound. Br J Urol 78 5 (1996) 715-721
12. Lizzi F.L., Deng C.X., Lee P., et al. A comparison of ultrasonic beams for thermal treatment of ocular tumors. Eur J Ultrasound 9 1 (1999) 71-78
13. Ishihara Y., Calderon A., Watanabe H., et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med 34 6 (1995) 814-823
14. Hynynen K., Vykhodtseva N.I., Chung A.H., et al. Thermal effects of focused ultrasound on the brain: determination with MR imaging. Radiology 204 1 (1997) 247-253
15. Chung A.H., Jolesz F.A., and Hynynen K. Thermal dosimetry of a focused ultrasound beam in vivo by magnetic resonance imaging. Med Phys 26 9 (1999) 2017-2026
16. McDannold N., Tempany C.M., Fennessy F.M., et al. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 240 1 (2006) 263-272
17. Chung A.H., Hynynen K., Colucci V., et al. Optimization of spoiled gradient-echo phase imaging for in vivo localization of focused ultrasound beam. Magn Reson Med 36 5 (1996) 745-752
18. Leon-Villapalos J., Kaniorou-Larai M., and Dziewulski P. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns 31 8 (2005) 1054-1055
19. Tempany C.M., Stewart E.A., McDannold N., et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 226 3 (2003) 897-905
20. Stewart E.A., Gedroyc W.M., Tempany C.M., et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 189 1 (2003) 48-54
21. Stewart E.A., Gostout B., Rabinovici J., et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 110 2 Pt 1 (2007) 279-287
22. Fennessy F.M., Tempany C., McDannold N., et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-results of different treatment protocols. Radiology 243 3 (2007) 885-893
23. Morrison P.R., Silverman S.G., Tuncali K., et al. MRI guided cryotherapy. J Magn Reson Imaging 27 2 (2008) 410-420
24. Sewell P.E., Arriola R.M., Robinette L., et al. Real-time I-MR-imaging-guided cryoablation of uterine fibroids. J Vasc Interv Radiol 12 7 (2001) 891-893
25. Cowan B.D., Sewell P.E., Howard J.C., et al. Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: preliminary observation. Am J Obstet Gynecol 186 6 (2002) 1183-1187
26. Dohi M., Harada J., Mogami T., et al. MR-guided transvaginal cryotherapy of uterine fibroids with a horizontal open MRI system: initial experience. Radiat Med 22 6 (2004) 391-397
27. Sakuhara Y., Shimizu T., Kodama Y., et al. Magnetic resonance-guided percutaneous cryoablation of uterine fibroids: early clinical experiences. Cardiovasc Intervent Radiol 29 4 (2006) 552-558
28. American Cancer Society. Cancer facts and figures 2007. Publication no. 500807 (2006), American Cancer Society, Atlanta (GA)
29. American Cancer Society. Cancer facts and figures. Publication no. 500807 (2008), American Cancer Society, Atlanta (GA)
30. Lee F., Gray J.M., McLeary R.D., et al. Prostatic evaluation by transrectal sonography: criteria for diagnosis of early carcinoma. Radiology 158 (1986) 91-95
31. Terris M.K. Sensitivity and specificity of sextant biopsies in the detection of prostate cancer; preliminary report. Urology 54 (1999) 486-489
32. Aus G., Hermansson C.G., Hugosson J., et al. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol 71 (1993) 457-459
33. Collins G.N., Lloyd S.N., Hehir M., et al. Multiple transrectal ultrasound-guided prostatic biopsies: true morbidity and patient acceptance. Br J Urol 71 (1993) 460-463
34. Rodriguez L.V., and Terris M.K. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective review of the literature. J Urol 160 (1998) 2115-2120
35. Rifkin M.D., Zerhouni E.A., Gatsonis C.A., et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 323 (1990) 621-626
36. Schnall M.D., and Pollack H.M. Magnetic resonance imaging of the prostate gland. Urol Radiol 12 2 (1990) 109-114
37. Cornud F., Flam T., Chauveinc L., et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224 1 (2002) 203-210
38. Outwater E.K., Petersen R.O., Siegelman E.S., et al. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193 2 (1994) 333-339
39. Mullerad M., Hricak H., Kuroiwa K., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174 (2005) 2158-2163
40. Perrotti M., Han K.R., Epstein R.E., et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 162 (1999) 1314-1317
41. Hata N., Morrison P.R., Kettenbach J., et al. Computer-assisted intra-operative MRI monitoring of interstitial laser therapy in the brain: a case report. SPIE J Biomed Optics 3 (1998) 302-311
42. Gering D, Nabavi A, Kikinis R, et al. An integrated visualization system for surgical planning and guidance using image fusion and interventional imaging. Medical Image Computing and Computer-Assisted Intervention (MICCAI), Cambridge, England September 22, 1999.
43. D'Amico A.V., Cormack R., Tempany C.M., et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 42 (1998) 507-515
44. Hata N., Jinzaki M., Kacher D., et al. MR imaging-guided prostate biopsy with surgical navigation software; device validation and feasibility. Radiology 220 (2001) 263-268
45. Susil R.C., Camphausen K., Choyke P., et al. System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med 52 3 (2004) 683-687
46. Susil R.C., Menard C., Kreiger A., et al. Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol 175 1 (2006) 113-120
47. Beyersdorff D., Winkel A., Hamm B., et al. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234 2 (2005) 576-581
48. Kreiger A., Susil R.C., Menard C., et al. Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng 52 2 (2005) 306-313
49. Singh A.K., Kreiger A., and Lattouf J.B. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int 101 12 (2008) 181-185
50. DiMaio S.P., Pieper S., Chinzei K., et al. Robot-assisted needle placement in open MRI: system architecture, integration and validation. Comput Aided Surg 12 1 (2007) 15-24
51. Lee W.R., Hall M.C., McQuellon R.P., et al. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 51 3 (2001) 614-623
52. Zelefsky M.J., Yamada Y., Marion C., et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 4 (2003) 956-963
53. Kooy H.M., Cormack R.A., Mathiowitz R.V., et al. A software system for interventional magnetic resonance image-guided prostate brachytherapy. Comput Aided Surg 5 6 (2000) 401-413
54. D'Amico A.V., Cormack R., Kumar S., et al. Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol 14 (2000) 367-370
55. Albert M., Tempany C.M., Schultz, et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 98 5 (2003) 949-954
56. Nguyen P.L., Chen M.H., D'Amico A.V., et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 110 7 (2007) 1485-1492
57. D'Amico A.V., Moul J., Carroll P.R., et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 21 11 (2003) 2163-2172
58. Sylvester J.E., Grimm P.D., Blasko J.C., et al. 5-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int J Radiat Oncol Biol Phys 67 1 (2007) 57-64
59. Lawton C.A., DeSilvo M., Lee W.R., et al. Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05). Int J Radiat Oncol Biol Phys 67 1 (2007) 39-47
60. Chinzei K., and Miller K. Towards MRI guided surgical manipulator. Med Sci Monit 7 (2001) 153-163
61. Poissonier L., Chapelon J.Y., Rouviere O., et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 51 2 (2007) 381-387
62. Uchida T., Ohkusa H., Nagata Y., et al. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 97 1 (2006) 56-61
63. Ficarra V., Antoniolli S.Z., Novara G., et al. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. BJU Int 98 6 (2006) 1193-1198
64. Smith N.B., Buchanan M.T., and Hynynen K. Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry. Int J Radiat Oncol Biol Phys 43 1 (1999) 217-225
65. Sokka S.D., and Hynynen K.H. The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound and phased array. Phys Med Biol 45 11 (2000) 3378-3383
66. Nau W.H., Diederich C.J., Ross A.B., et al. MRI-guided interstitial ultrasound thermal therapy of the prostate: a feasibility study in the canine model. Med Phys 32 3 (2005) 733-743
67. Pauly K.B., Diedrich C.J., Rieke V., et al. Magnetic resonance-guided high-intensity ultrasound ablation of the prostate. Top Magn Reson Imaging 17 3 (2006) 195-207
68. Diederich C.J., Nau W.H., Ross A.B., et al. Catheter-based ultrasound applicators for selective thermal ablation: progress towards MRI-guided applications in prostate. Int J Hyperthermia 20 7 (2004) 739-756
69. Diederich C.J., Stafford R.J., Nau W.H., et al. Transurethral ultrasound applicators with directional heating patterns for prostate thermal therapy: in vivo evaluation using magnetic resonance thermometry. Med Phys 31 2 (2004) 405-413
70. Hazle J.D., Diederich C.J., Kangasniemi M., et al. MRI-guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator. J Magn Reson Imaging 15 4 (2002) 409-417
71. Chopra R., Burtnyk M., Haider M.A., et al. Method for MRI-guided conformal thermal therapy of prostate with planar transurethral ultrasound heating applicators. Phys Med Biol 50 21 (2005) 4957-4975
72. Ross A.B., Diederich C.J., Nau W.H., et al. Highly directional transurethral ultrasound applicators with rotational control for MRI guided prostatic thermal therapy. Phys Med Biol 49 1 (2004) 189-204
73. Ross A.B., Diederich C.J., Nau W.H., et al. Curvilinear transurethral ultrasound applicator for selective prostate thermal therapy. Med Phys 32 6 (2005) 1555-1565
74. Godley P.A., and Ataga K.I. Renal cell carcinoma. Curr Opin Oncol 12 (2000) 260-264
75. Chow W.H., Devesa S.S., Warren J.L., et al. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628-1631
76. Link R.E., Permpongkosol S., Gupta A., et al. Cost analysis of open, laparoscopic, and percutaneous treatment options for nephron-sparing surgery. J Endourol 20 (2006) 782-789
77. Gervais D.A., McGovern F.J., Wood B.J., et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 217 (2000) 665-672
78. Ogan K., Jacomides L., Dolmatch B.L., et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology 60 (2002) 954-958
79. Farrell M.A., Charboneau W.J., DiMarco D.S., et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR 180 (2003) 1509-1513
80. Mayo-Smith W.W., Dupuy D.E., Parikh P.M., et al. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: technique and outcomes of 38 treatment sessions in 32 consecutive patients. AJR 180 (2003) 1503-1508
81. Roy-Choudhury S.H., Cast J.E., Cooksey G., et al. Early experience with percutaneous radiofrequency ablation of small solid renal masses. AJR 180 (2003) 1055-1061
82. Su L.M., Jarrett T.W., Chan D.Y.S., et al. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 61 (2003) 26-33
83. Zagoria R.J., Hawkins A.D., Clark P.E., et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR 183 (2004) 201-207
84. Gervais D.A., McGovern F.J., Arellano R.S., et al. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over 6-year period and ablation of 100 tumors. AJR 185 (2005) 64-71
85. Varkarakis I.M., Allaf M.E., Inagaki T., et al. Percutaneous radiofrequency ablation of renal masses: results at a 2-year mean followup. J Urol 174 (2005) 456-460
86. Lewin J.S., Connell C.F., Duerk J.L., et al. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. JMRI 8 (1998) 40-47
87. Lewin J.S., Nour S.G., Connell C.F., et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology 232 3 (2004) 835-845
88. Merkle E.M., Shonk J.R., Duerk J.L., et al. MR-guided RF thermal ablation of the kidney in a porcine model. AJR Am J Roentgenol 173 3 (1999) 645-651
89. Boss A., Clasen S., Kuczyk M., et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol 40 9 (2005) 583-590
90. Boss A., Clasen S., Kuczyk M., et al. Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 17 3 (2007) 725-733
91. Merkle E.M., Nour S.G., and Lewin J.S. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 235 3 (2005) 1065-1071
92. Memarsadeghi M., Schmook T., Remzi M., et al. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Eur J Radiol 59 2 (2006) 183-189
93. Kawamoto S., Permpongkosol S., Bluemke D.A., et al. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics 27 2 (2007) 343-355
94. Atwell T.D., Farrell M.A., Callstrom M.R., et al. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology 243 (2007) 276-283
95. Atwell T.D., Farrell M.A., Callstrom M.R., et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR 188 (2007) 1195-1200
96. Matina S.F., Ahrarb K., Cadedduc J.A., et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 176 (2006) 1973-1977
97. Allaf M.E., Varkarakis I.M., Bhayani S.B., et al. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation-initial observations. Radiology 237 (2005) 366-370
98. Tacke J., Speetzen R., Heschel I., et al. Imaging of interstitial cryotherapy-an in vitro comparison of ultrasound, computed tomography, and magnetic resonance imaging. Cryobiology 38 (1999) 250-259
99. Saliken J., McKinnon J., and Gray R. CT for monitoring cryotherapy. AJR 166 (1996) 853-855
100. Sandison G.A., Loye M.P., Rewcastle J.C., et al. X-ray CT monitoring of iceball growth and thermal distribution during cryosurgery. Phys Med Biol 43 (1998) 3309-3324
101. Gupta A., Allaf M.E., Kavoussi L.R., et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol 175 (2006) 447-453
102. Permpongkosol S., Link R.E., Kavoussi L.R., et al. Percutaneous computerized tomography guided cryoablation for localized renal cell carcinoma: factors influencing success. J Urol 176 (2006) 1963-1968
103. Littrup P.J., Ahmed A., Aoun H.D., et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol 18 (2007) 383-392
104. Harada J., Dohi M., Mogami T., et al. Initial experience of percutaneous renal cryosurgery under the guidance of a horizontal open MRI system. Radiat Med 19 (2001) 291-296
105. Shingleton W.B., Sewell J., and Patrick E. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol 165 (2001) 773-776
106. Shingleton W.B., and Sewell P.E. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease. J Urol 167 (2002) 1268-1270
107. Shingleton W.B., and Sewell P.E. Percutaneous cryoablation of renal cell carcinoma in a transplanted kidney. BJU International 90 (2002) 137-138
108. Sewell P.E., Howard J.C., Shingleton W.B., et al. Interventional magnetic resonance image-guided percutaneous cryoablation of renal tumors. South Med J 96 (2003) 708-710
109. Shingleton W.B., and Sewell P.E. Cryoablation of renal tumours in patients with solitary kidneys. BJU International 92 (2003) 237-239
110. Kodama Y., Abo D., Sakuhara Y., et al. MR-guided percutaneous cryoablation for bilateral multiple renal cell carcinoma. Radiat Med 23 (2005) 303-307
111. Silverman S.G., Tuncali K., vanSonnenberg E., et al. Renal tumors: MR imaging guided percutaneous cryotherapy-initial experience in 23 patients. Radiology 236 (2005) 716-724
112. Miki K., Shimomura T., Yamada H., et al. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. Int J Urol 13 (2006) 880-884
113. Silverman S.G., Tuncali K., Adams D.F., et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217 (2000) 657-664
114. Farrell M.A., Charboneau J.W., Callstrom M.R., et al. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR 181 (2003) 1315-1317
115. Tuncali K., Morrison P.R., Tatli S., et al. MRI-guided percutaneous cryoablation of renal tumors: use of external manual displacement of adjacent bowel loops. Eur J Radiol 59 (2006) 198-202
116. Elhawary H., Zivanovic A., Davies B., et al. A review of magnetic resonance imaging compatible manipulators in surgery. Proc Inst Mech Eng [H] 220 3 (2006) 413-424